Several previous studies have suggested that IL-33 contributes to the pathogenesis of autoimmune diseases [16], especially in patients with SLE and lupus nephritis; the expression of IL-33 and its receptor ST2 is significantly upregulated [17]. This evidence concerns the gene IL33 and autoimmune disease.